Utility Requirement in Canada
description
Transcript of Utility Requirement in Canada
![Page 1: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/1.jpg)
Utility Requirement in Canada
![Page 2: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/2.jpg)
2
Section 2 of the Patent Act:
“invention” means
any new and useful art, process, machine,
manufacture or composition of matter, or
any new and useful improvement in any art, process,
machine, manufacture or composition of matter.
![Page 3: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/3.jpg)
3
“Consolboard”:
“There is a helpful discussion in Halsbury's Laws of England, (3rd ed.), vol. 29, at p. 59, on the meaning of "not useful" in patent law. It means "that the invention will not work, either in the sense that it will not operate at all or, more broadly, that it will not do what the specification promises that it will do".
Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd. (1981), 56 C.P.R. (2d) 145 (S.C.C.) at
160, quoting from Halsbury’s Laws of England, (3rd ed.), vol. 29
![Page 4: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/4.jpg)
4
Level of Utility
“... it is sufficient utility to support a patent that the invention gives either a new article, or a better article, or a cheaper article, or affords the public a useful choice.”
An invention’s commercial utility does not mater, “unless the specification promises commercial utility”
![Page 5: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/5.jpg)
5
Promise of Utility• when a patent makes an explicit promise of utility,
the utility will be measured against that promise
• question of law
• Not every patent contains an explicit promise of a specific result since there is no obligation on the part of the inventor to disclose the utility of his invention in the patent.
![Page 6: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/6.jpg)
6
Utility
• demonstrated
• soundly predicted
as of the filing date
![Page 7: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/7.jpg)
7
• Promise of Utility
• Demonstration of Utility
• Sound Prediction
![Page 8: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/8.jpg)
8
Promise of Utility:
• “the promise should be properly defined, within the
context of the patent as a whole”
• usually express statements of the description
![Page 9: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/9.jpg)
9
What is Construed as a Promise of Utility:
“carboxyalkyldipeptides which are useful as inhibitors of angiotensin-converting enzyme and as anti-hypertensive agents.” (Yes/No)
“[i]t is a particular object of the present invention to provide aromatase inhibitory compounds with fewer undesirable side effects than aminoglutethimide”.(No)
![Page 10: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/10.jpg)
10
Demonstrated Utilityno requirement to prove demonstrated utility in the
disclosure.
disclosure requirements are set out in the
subsection 27(3) of the Patent Act
![Page 11: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/11.jpg)
11
Sound Prediction
(i) a factual basis;
(ii) an articulable and sound line of reasoning from
which the desired result can be inferred from
the factual basis; and
(iii) proper disclosure
![Page 12: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/12.jpg)
12
Factual basis
• not necessarily limited to experimental data/testing• “other factual underpinnings, depending on the
nature of the invention, may suffice” • e.g. scientifically accepted laws or principles, in data
forming part of the state of the art and which is referred to in the description, or in information forming part of the common general knowledge of the person skilled in the art
![Page 13: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/13.jpg)
13
an articulable and sound line of reasoning from which the desired result can be inferred from the factual basis
• “prima facie reasonable inference of utility”
• utility of AZT in humans was reasonably inferred
from the testing data obtained from human cell lines
and animals
![Page 14: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/14.jpg)
14
Plavix® (sanofi-aventis v. Apotex Inc., 2013 FCA 186 decision)welcome clarification to the relationship between the requirement that an invention be useful and the promise doctrine
• “… Courts should not strive to find ways to defeat otherwise valid patents.”
• The trial judge “erred in law in reading into the ‘777 patent a promise for use in humans on the basis of interferences”
![Page 15: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/15.jpg)
15
Plavix® (sanofi-aventis v. Apotex Inc., 2013 FCA 186 decision)• “A goal is not necessarily a promise”;
• distinction between statements made in the patent’s
disclosure originated from the foreign application
and statements of utility made in the claims
![Page 16: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/16.jpg)
16
Plavix® (sanofi-aventis v. Apotex Inc., 2013 FCA 186 decision)
• “The Supreme Court of Canada’s comments in Consolboard with respect to a promise of specific result were made in a case raising issues of demonstrated utility. I believe that one must be particularly prudent when one seeks to extend Consolboard’s principles to statements clearly based on expectations.”
![Page 17: Utility Requirement in Canada](https://reader035.fdocuments.in/reader035/viewer/2022062520/568161ba550346895dd19107/html5/thumbnails/17.jpg)
montréal · ottawa · toronto · hamilton · waterloo region · calgary · vancouver · moscow · london
Thank You
Xiang LuTel: +1-613-786-8680Email:[email protected]